相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combination of targeted agents in metastatic renal cell carcinoma
M. Dror Michaelson
CANCER (2012)
Phase 1 Trial of Everolimus Plus Sunitinib in Patients With Metastatic Renal Cell Carcinoma
Ana M. Molina et al.
CANCER (2012)
Lenalidomide - Current Understanding of Mechanistic Properties
Nishant Tageja
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2011)
Therapeutic Effect of Lenalidomide in a Novel Xenograft Mouse Model of Human Blastic NK Cell Lymphoma/Blastic Plasmacytoid Dendritic Cell Neoplasm
Alice Agliano et al.
CLINICAL CANCER RESEARCH (2011)
Future Directions in Renal Cell Carcinoma: 2011 and Beyond
Daniel C. Cho et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2011)
Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function
A. K. Gandhi et al.
CURRENT CANCER DRUG TARGETS (2010)
Increased numbers of small circulating endothelial cells in renal cell cancer patients treated with sunitinib
Laura Vroling et al.
ANGIOGENESIS (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Phase I Trial of Bevacizumab Plus Escalated Doses of Sunitinib in Patients With Metastatic Renal Cell Carcinoma
Darren R. Feldman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Combining agents that target the tumor microenvironment improves the efficacy of anticancer therapy
Joseph A. Blansfield et al.
CLINICAL CANCER RESEARCH (2008)
Phase II trial of lenalidomide in patients with metastatic renal cell carcinoma
Premal H. Patel et al.
INVESTIGATIONAL NEW DRUGS (2008)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Phase II study of lenalidomide in patients with metastatic renal cell carcinoma
Toni K. Choueiri et al.
CANCER (2006)
分享论文
